(Q33694139)

28 July 2017

title

Consideration of ethics in primaquine therapy against malaria transmission (English)

1 reference

28 July 2017

0 references

0 references

1

J Kevin Baird

1 reference

28 July 2017

Claudia Surjadjaja

2

1 reference

28 July 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20846906

14 July 2024

publication date

16 September 2010

1 reference

full work available at URL

28 July 2017

https://api.elsevier.com/content/article/PII:S1471492210001765?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/J.PT.2010.08.005

https://api.elsevier.com/content/article/PII:S1471492210001765?httpAccept=text/plain

14 July 2024

1 reference

https://api.crossref.org/works/10.1016/J.PT.2010.08.005

14 July 2024

published in

Trends in Parasitology

1 reference

28 July 2017

volume

27

1 reference

28 July 2017

issue

1

1 reference

28 July 2017

page(s)

11-16

1 reference

Infectivity to mosquitoes of Plasmodium vivax following treatment with chloroquine and other antimalarials.

28 July 2017

cites work

1

1 reference

https://api.crossref.org/works/10.1016/J.PT.2010.08.005

Activities of artesunate and primaquine against asexual- and sexual-stage parasites in falciparum malaria

14 July 2024

2

1 reference

https://api.crossref.org/works/10.1016/J.PT.2010.08.005

Mapping the global extent of malaria in 2005.

14 July 2024

4

1 reference

https://api.crossref.org/works/10.1016/J.PT.2010.08.005

Natural selection of hemi- and heterozygotes for G6PD deficiency in Africa by resistance to severe malaria

14 July 2024

5

1 reference

https://api.crossref.org/works/10.1016/J.PT.2010.08.005

The global prevalence of glucose-6-phosphate dehydrogenase deficiency: a systematic review and meta-analysis

14 July 2024

6

1 reference

https://api.crossref.org/works/10.1016/J.PT.2010.08.005

Primaquine, SN 13272, a new curative agent in vivax malaria; a preliminary report

14 July 2024

7

1 reference

https://api.crossref.org/works/10.1016/J.PT.2010.08.005

Enzymatic Deficiency in Primaquine-Sensitive Erythrocytes

14 July 2024

8

1 reference

https://api.crossref.org/works/10.1016/J.PT.2010.08.005

The hemolytic effect of primaquine. II. The natural course of the hemolytic anemia and the mechanism of its self-limited character

14 July 2024

9

1 reference

https://api.crossref.org/works/10.1016/J.PT.2010.08.005

Primaquine sensitivity in Caucasians: hemolytic reactions induced by primaquine in G-6-PD deficient subjects

14 July 2024

11

1 reference

https://api.crossref.org/works/10.1016/J.PT.2010.08.005

Gametocytocidal and sporontocidal effects of primaquine and of sulfadiazine with pyrimethamine in a chloroquine-resistant strain of Plasmodium falciparum

14 July 2024

13

1 reference

https://api.crossref.org/works/10.1016/J.PT.2010.08.005

Mass administration of an antimalarial drug combining 4-aminoquinoline and 8-aminoquinoline in Tanganyika

14 July 2024

16

1 reference

https://api.crossref.org/works/10.1016/J.PT.2010.08.005

Primaquine induced haemolysis in G-6-PD deficient Burmese

14 July 2024

18

1 reference

https://api.crossref.org/works/10.1016/J.PT.2010.08.005

Sensitivity to primaquine in Ceylonese children due to deficiency of erythrocytic glucose-6-phosphate dehydrogenase

14 July 2024

20

1 reference

https://api.crossref.org/works/10.1016/J.PT.2010.08.005

Clinical problems associated with the use of primaquine as a tissue schizontocidal and gametocytocidal drug

14 July 2024

23

1 reference

https://api.crossref.org/works/10.1016/J.PT.2010.08.005

Effect of intermittent administration of a combination of amodiaquin and primaquine (Camoprim) on the hematocrit of primaquine-sensitive and non-sensitive children

14 July 2024

24

1 reference

https://api.crossref.org/works/10.1016/J.PT.2010.08.005

The Tolerance to Large Weekly Doses of Primaquine and Amodiaquine in Primaquine-Sensitive and Nonsensitive Subjects *

14 July 2024

25

1 reference

https://api.crossref.org/works/10.1016/J.PT.2010.08.005

Primaquine clears submicroscopic Plasmodium falciparum gametocytes that persist after treatment with sulphadoxine-pyrimethamine and artesunate

14 July 2024

26

1 reference

https://api.crossref.org/works/10.1016/J.PT.2010.08.005

In Tanzania, hemolysis after a single dose of primaquine coadministered with an artemisinin is not restricted to glucose-6-phosphate dehydrogenase-deficient (G6PD A-) individuals

14 July 2024

27

1 reference

https://api.crossref.org/works/10.1016/J.PT.2010.08.005

Strong gametocytocidal effect of methylene blue-based combination therapy against falciparum malaria: a randomised controlled trial

14 July 2024

29

1 reference

https://api.crossref.org/works/10.1016/J.PT.2010.08.005

Failure of artesunate-mefloquine combination therapy for uncomplicated Plasmodium falciparum malaria in southern Cambodia

14 July 2024

30

1 reference

https://api.crossref.org/works/10.1016/J.PT.2010.08.005

Artemisinin Resistance in Plasmodium falciparum Malaria

14 July 2024

31

1 reference

https://api.crossref.org/works/10.1016/J.PT.2010.08.005

The chemotherapy of rodent malaria. LXI. Drug combinations to impede the selection of drug resistance, part 4: the potential role of 8-aminoquinolines

14 July 2024

32

1 reference

https://api.crossref.org/works/10.1016/J.PT.2010.08.005

The role of anti-malarial drugs in eliminating malaria

14 July 2024

33

1 reference

https://api.crossref.org/works/10.1016/J.PT.2010.08.005

14 July 2024

Identifiers

1 reference

28 July 2017

1 reference